Clik here to view.
Terumo BCT Opens Manufacturing Facility in Vietnam
LAKEWOOD, Colo. Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced the opening of its new 91,440-square-meter facility near Ho Chi Minh...
View ArticleClik here to view.
Terumo BCT在越南的制造工厂开张
科罗拉多州LAKEWOOD (美国商业资讯) — 血液成分、治疗性血浆分离置换法和细胞技术的全球领先者Terumo BCT今天宣布，其在越南胡志明市附近开张了一家面积达91,440平方米的新工厂。该设施投资1亿美元，为Terumo BCT的全球业务扩张提供支持。当制造运营于2015年上半年开始时，这一新的制造工厂将提供增加的产能。 Terumo BCT在越南的新制造工厂。（照片：美国商业资讯）...
View ArticleClik here to view.
テルモBCTがベトナムの製造施設を開所
米コロラド州レイクウッド （ビジネスワイヤ） — 血液成分・治療用アフェレシス・細胞技術の世界的リーダーであるテルモBCTは本日、ベトナムのホーチミン市近郊における9万1440平方メートルの新施設の開所を発表しました。1億ドルの本製造施設はテルモBCTの事業拡大を世界規模で支えるものです。2015年前半に製造業務が開始されれば、この新しい製造施設は当社の製造能力を増強することになります。...
View ArticleClik here to view.
ReproCELL Expects Synergy and Business Benefits through the Acquisitions of...
YOKOHAMA, Japan ReproCELL (JASDAQ:4978) was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business,...
View ArticleClik here to view.
ZRG Partners Life Sciences Hiring Index Q2 Declines Slightly but Still Near...
WEST ORANGE, N.J. ZRG Partners, Inc. announces the results of its second quarter Global Life Sciences Hiring Index. Q2 displays a slightly negative turn but the overall outlook remains positive with...
View ArticleClik here to view.
Terumo BCT宣布合作项目，以评估采用Quantum系统进行细胞临床生产
科罗拉多州LAKEWOOD (美国商业资讯) — Athersys, Inc.是一家致力于干细胞疗法研发的生物制药公司，该公司正在评估Terumo BCT的Quantum® Cell Expansion System能否作为Athersys的同种异源多能成体祖细胞(MAPC®)产品的制造平台。Athersys在比利时的分公司ReGenesys BVBA将担当此次评估。...
View ArticleClik here to view.
The International Bio-Community Meets in Japan!Announcing Integrated Biotech...
TOKYO BioJapan 2014 – World Business Forum – will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition Halls C & D, and Annex Hall). BioJapan...
View ArticleClik here to view.
バイオ先進国日本から世界へ発信！バイオビジネスの総合イベントBioJapan 2014開催
東京 （ビジネスワイヤ） — 来る2014年10月15日（水）～17日（金）の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2014 – World Business Forum – を開催します。 BioJapan 2013 – Partnering Area – (Photo: Business Wire) BioJapan...
View ArticleClik here to view.
国际生物界人士齐聚日本！综合性生物技术商业盛会——BioJapan 2014即将举办
东京 (美国商业资讯)–BioJapan 2014 – 世界商业论坛 –将于2014年10月15（周三）-17日（周五）在横滨太平洋会展中心(Pacifico Yokohama)的C馆、D馆及分馆举行，为期三天。 BioJapan 2013 – Partnering Area – (Photo: Business Wire)...
View ArticleClik here to view.
ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.
YOKOHAMA, Japan ReproCELL (JASDAQ:4978) announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. This acquisition allows the ReproCELL Group to expand the product lineups of its...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA...
BOTHELL, Wash. & OSAKA, Japan Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received...
View ArticleClik here to view.
ReproCELL Launches Cell Innovation Partners, L.P. with Shinsei Bank, Limited
YOKOHAMA, Japan ReproCELL (JASDAQ:4978) announced that it has commenced operation of “Cell Innovation Partners, L.P.” (hereafter “the Fund”) at the size of about USD 8.0 million, as of September 26,...
View ArticleClik here to view.
Tokyo Electron Launches its Open Innovation Stem Cell Technology Centre (STC)...
TOKYO Tokyo Electron Limited (TEL) opened, through its European subsidiary Tokyo Electron Europe Limited (TEE), the company’s open innovation centre at Stevenage Bioscience Catalyst (SBC) in the...
View ArticleClik here to view.
【 BioJapan 】 － アジア最大級のバイオ総合展 －世界のバイオ企業が日本に熱視線！ビッグファーマ・ベンチャー・アカデミアが創る新バイオビジネス
東京 （ビジネスワイヤ） — 来る2014年10月15日（水）～17日（金）の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2014 – World Business Forum – を開催します。 BioJapan...
View ArticleClik here to view.
Seattle Genetics与武田发布 ADCETRIS® (Brentuximab...
华盛顿州博瑟尔和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)今天宣布，自体干细胞移植(ASCT)后立即接受ADCETRIS (brentuximab...
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品が移植後ホジキンリンパ腫治療の地固め療法としてのアドセトリス（ブレンツキシマブ・ベドチン）の第3相AETHERA臨床試験...
米ワシントン州ボセル & 大阪 （ビジネスワイヤ） — シアトル・ジェネティクス（Nasdaq:...
View ArticleClik here to view.
Cytori Therapeutics Invited to Participate in Trade Mission to Asia with U.S....
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) has been selected to participate in a U.S. trade mission to Japan and South Korea led by the U.S. Secretary of Commerce Penny Pritzker. The...
View ArticleClik here to view.
The 1st Meeting of the Series Bridging Biomedical Worlds: “Turning Obstacles...
PARIS Stem cells hold great promise for treating a variety of human diseases and injuries. Basic and translational stem cell research is among the most competitive fields in the life sciences. We...
View ArticleClik here to view.
Akebia Announces Positive Top-Line Results from its Phase 2b Study of...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia...
View ArticleClik here to view.
Akebiaが慢性腎臓病に関連した貧血を伴う非透析患者を対象にAKB-6548を検討した第2b相試験で、優れて良好な結果が得られたと発表
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 低酸素誘導因子（HIF）の生物学を通じて腎臓病患者に革新的治療薬を提供することに傾注するバイオ製薬企業のAkebia Therapeutics,...
View Article